Correlation Between Elevation Oncology and Eledon Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Elevation Oncology and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Eledon Pharmaceuticals.

Diversification Opportunities for Elevation Oncology and Eledon Pharmaceuticals

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Elevation and Eledon is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Elevation Oncology and Eledon Pharmaceuticals

Given the investment horizon of 90 days Elevation Oncology is expected to generate 4.82 times less return on investment than Eledon Pharmaceuticals. But when comparing it to its historical volatility, Elevation Oncology is 1.25 times less risky than Eledon Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  337.00  in Eledon Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  64.00  from holding Eledon Pharmaceuticals or generate 18.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Elevation Oncology  vs.  Eledon Pharmaceuticals

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Eledon Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Elevation Oncology and Eledon Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Eledon Pharmaceuticals

The main advantage of trading using opposite Elevation Oncology and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.
The idea behind Elevation Oncology and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas